International Patent: USE OF CNP OR CNP CONJUGATES SUCH AS NAVEPEGRITIDE TO TREAT LEG CURVATURE IN PATIENTS WITH SKELETAL DYSPLASIA

GENEVA, July 6 -- ASCENDIS PHARMA GROWTH DISORDERS A/S filed a patent application (EP2025/088714) for “USE OF CNP OR CNP CONJUGATES SUCH AS NAVEPEGRITIDE TO TREAT LEG CURVATURE IN PATIENTS WITH SKELETAL DYSPLASIA”. With publication no. WO/2026/139471, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/65

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....